| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | +0.0% |
| R&D Expense | $17.1M | -4.3% |
| SG&A Expense | $11.8M | -15.2% |
| Operating Income | -$28.9M | -0.8% |
| Pre-tax Income | -$18.6M | -365.9% |
| Net Income | -$17.4M | -316.9% |
| EPS (Basic) | -$1.42 | -190.4% |
| EPS (Diluted) | -$1.42 | -190.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.9M | -25.3% |
| Current Assets | $19.1M | -30.5% |
| Total Assets | $24.8M | -27.4% |
| Current Liabilities | $7.2M | -17.0% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $12.6M | -22.3% |
| Stockholders' Equity | $12.2M | -32.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.7M | +44.2% |
| Capital Expenditures | $29K | +0.0% |
| Investing Cash Flow | -$29K | +0.0% |
| Financing Cash Flow | $6.0M | +329.3% |
| Free Cash Flow | -$11.8M | +44.1% |